옵션 체인은 다양한 행사가격과 만기일에 대한 Bancorp의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Bancorp에 대한 시장 심리를 평가합니다..

Bancorp (NASDAQ:TBBK) 주식, 옵션 체인

Bancorp

The Bancorp Inc is a financial holding company, through its subsidiary it is engaged in specialty lending namely securities-backed lines of credit, vehicle fleet and another equipment leasing, Small Business Administration lending, insurance policy cash value-backed lines of credit and commercial mortgage-backed loans, generated for sale into commercial mortgage-backed securities markets through securitizations. The company deposits and non-interest income are generated in the payments business which consists of issuing, acquiring, and automated clearing house accounts.

The Bancorp

The Bancorp Inc

<p>Keefe, Bruyette &amp; Woods  analyst Timothy Switzer   maintains Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBBK#NASDAQ">TBBK</a>) with a Outperform and raises the price target from $66 to $72.</p>


News

Price Target

Analyst Ratings

TBBK

Keefe, Bruyette & Woods Maintains Outperform on Bancorp, Raises Price Target to $72

<p>Raymond James  analyst David Feaster   reiterates Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBBK#NASDAQ">TBBK</a>) with a Outperform and raises the price target from $60 to $67.</p>


Reiteration

Raymond James Reiterates Outperform on Bancorp, Raises Price Target to $67

WIIM

Bancorp shares are trading higher after the company reported Q4 financial results and beat EPS estimates.

<p><strong>Bancorp</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBBK#NASDAQ">TBBK</a>) announced its Q4 earnings on Thursday, January 30, 2025 at 04:05 PM.</p>
<p>Here's a breakdown of the earnings report.</p>
<h3>Earnings</h3>
<p>Bancorp beat estimated earnings by 2.0%, reporting an EPS of $1.15 versus an estimate of $1.13.</p>
<p>Revenue was up $2.14 million from the same period last year.</p>
<h3>Previous Earnings Records</h3>
<p>During the previous quarter, the company missed on EPS by $0.08, leading to a 14.000000000000002% drop share price change the next day.</p>
<p>Here's a look at Bancorp's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.12</td>
<td>1.07</td>
<td>1.05</td>
<td>0.95</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.04</td>
<td>1.07</td>
<td>1.06</td>
<td>0.95</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>99.31M</td>
<td>96.41M</td>
<td>116.51M</td>
<td>90.65M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>93.73M</td>
<td>93.80M</td>
<td>94.42M</td>
<td>92.16M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Bancorp management provided guidance for FY 2025, expecting earnings between $5.25 and $5.25 per share.</p>
<p>To track all earnings releases for Bancorp <a href="https://www.benzinga.com/quote/TBBK/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings

Bancorp Q4 Earnings Assessment

<p><strong>Bancorp</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBBK#NASDAQ">TBBK</a>) announced its Q4 earnings on Thursday, January 30, 2025 at 04:05 PM.</p>
<p>Here's a breakdown of the earnings report.</p>
<h3>Earnings</h3>
<p>Bancorp beat estimated earnings by 2.0%, reporting an EPS of $1.15 versus an estimate of $1.13.</p>
<p>Revenue was up $2.14 million from the same period last year.</p>
<h3>Overview of Past Earnings</h3>
<p>The company missed on EPS by $0.08 in the previous quarter, leading to a 14.000000000000002% drop share price change the next day.</p>
<p>Here's a look at Bancorp's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.12</td>
<td>1.07</td>
<td>1.05</td>
<td>0.95</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.04</td>
<td>1.07</td>
<td>1.06</td>
<td>0.95</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>99.31M</td>
<td>96.41M</td>
<td>116.51M</td>
<td>90.65M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>93.73M</td>
<td>93.80M</td>
<td>94.42M</td>
<td>92.16M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Bancorp management provided guidance for FY 2025, expecting earnings between $5.25 and $5.25 per share.</p>
<p>To track all earnings releases for Bancorp <a href="https://www.benzinga.com/quote/TBBK/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Bancorp: Q4 Earnings Insights

<p><strong>Bancorp</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBBK#NASDAQ">TBBK</a>) released its Q4 earnings on Thursday, January 30, 2025 at 04:05 PM.</p>
<p>Here's what's important from the earnings announcement.</p>
<h3>Earnings</h3>
<p>Bancorp beat estimated earnings by 2.0%, reporting an EPS of $1.15 versus an estimate of $1.13.</p>
<p>Revenue was up $2.14 million from the same period last year.</p>
<h3>Previous Earnings Records</h3>
<p>Last quarter the company missed on EPS by $0.08 which was followed by a 14.000000000000002% drop in the share price the next day.</p>
<p>Here's a look at Bancorp's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.12</td>
<td>1.07</td>
<td>1.05</td>
<td>0.95</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.04</td>
<td>1.07</td>
<td>1.06</td>
<td>0.95</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>99.31M</td>
<td>96.41M</td>
<td>116.51M</td>
<td>90.65M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>93.73M</td>
<td>93.80M</td>
<td>94.42M</td>
<td>92.16M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Bancorp management provided guidance for FY 2025, expecting earnings between $5.25 and $5.25 per share.</p>
<p>To track all earnings releases for Bancorp <a href="https://www.benzinga.com/quote/TBBK/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Bancorp Earnings Review: Q4 Summary

<p><strong>Bancorp</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBBK#NASDAQ">TBBK</a>) released its Q4 earnings on Thursday, January 30, 2025 at 04:05 PM.</p>
<p>Here's what's important from the earnings announcement.</p>
<h3>Earnings</h3>
<p>Bancorp beat estimated earnings by 2.0%, reporting an EPS of $1.15 versus an estimate of $1.13.</p>
<p>Revenue was up $2.14 million from the same period last year.</p>
<h3>Past Earnings Performance</h3>
<p>Last quarter the company missed on EPS by $0.08 which was followed by a 14.000000000000002% drop in the share price the next day.</p>
<p>Here's a look at Bancorp's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.12</td>
<td>1.07</td>
<td>1.05</td>
<td>0.95</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.04</td>
<td>1.07</td>
<td>1.06</td>
<td>0.95</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>99.31M</td>
<td>96.41M</td>
<td>116.51M</td>
<td>90.65M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>93.73M</td>
<td>93.80M</td>
<td>94.42M</td>
<td>92.16M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Bancorp management provided guidance for FY 2025, expecting earnings between $5.25 and $5.25 per share.</p>
<p>To track all earnings releases for Bancorp <a href="https://www.benzinga.com/quote/TBBK/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings Breakdown: Bancorp Q4

<p><strong>Bancorp</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBBK#NASDAQ">TBBK</a>) just disclosed its Q4 earnings on Thursday, January 30, 2025 at 04:05 PM.</p>
<p>Here's a brief overview of the earnings report.</p>
<h3>Earnings</h3>
<p>Bancorp beat estimated earnings by 2.0%, reporting an EPS of $1.15 versus an estimate of $1.13.</p>
<p>Revenue was up $2.14 million from the same period last year.</p>
<h3>Overview of Past Earnings</h3>
<p>The company missed on EPS by $0.08 in the last quarter, resulting in a 14.000000000000002% drop share price change the following day.</p>
<p>Here's a look at Bancorp's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.12</td>
<td>1.07</td>
<td>1.05</td>
<td>0.95</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.04</td>
<td>1.07</td>
<td>1.06</td>
<td>0.95</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>99.31M</td>
<td>96.41M</td>
<td>116.51M</td>
<td>90.65M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>93.73M</td>
<td>93.80M</td>
<td>94.42M</td>
<td>92.16M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Bancorp management provided guidance for FY 2025, expecting earnings between $5.25 and $5.25 per share.</p>
<p>To track all earnings releases for Bancorp <a href="https://www.benzinga.com/quote/TBBK/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Insights into Bancorp Q4 Earnings

<p><strong>Bancorp</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBBK#NASDAQ">TBBK</a>) released its Q4 earnings on Thursday, January 30, 2025 at 04:05 PM.</p>
<p>Here's what's important from the earnings announcement.</p>
<h3>Earnings</h3>
<p>Bancorp beat estimated earnings by 2.0%, reporting an EPS of $1.15 versus an estimate of $1.13.</p>
<p>Revenue was up $2.14 million from the same period last year.</p>
<h3>Previous Earnings Records</h3>
<p>The company missed on EPS by $0.08 in the last quarter, resulting in a 14.000000000000002% drop share price change the following day.</p>
<p>Here's a look at Bancorp's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.12</td>
<td>1.07</td>
<td>1.05</td>
<td>0.95</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.04</td>
<td>1.07</td>
<td>1.06</td>
<td>0.95</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>99.31M</td>
<td>96.41M</td>
<td>116.51M</td>
<td>90.65M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>93.73M</td>
<td>93.80M</td>
<td>94.42M</td>
<td>92.16M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Bancorp management provided guidance for FY 2025, expecting earnings between $5.25 and $5.25 per share.</p>
<p>To track all earnings releases for Bancorp <a href="https://www.benzinga.com/quote/TBBK/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Recap: Bancorp Q4 Earnings

<p>Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBBK#NASDAQ">TBBK</a>) affirms FY2025 GAAP EPS guidance from $5.25 to $5.25 vs $5.24 analyst estimate..</p>


Guidance

Bancorp Affirms FY2025 GAAP EPS Guidance from $5.25 to $5.25 vs $5.24 Est

<p>Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBBK#NASDAQ">TBBK</a>) reported quarterly earnings of $1.15 per share which beat the analyst consensus estimate of $1.13 by 1.77 percent. This is a 21.05 percent increase over earnings of $0.95 per share from the same period last year.  The company reported quarterly sales of $94.30 million which missed the analyst consensus estimate of $96.76 million by 2.55 percent.  This is a 2.32 percent increase over sales of $92.16 million the same period last year.</p>


Earnings Beats

Earnings Misses

Bancorp Q4 EPS $1.15 Beats $1.13 Estimate, Sales $94.30M Miss $96.76M Estimate

<p><strong>Bancorp</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBBK#NASDAQ">TBBK</a>) announced its Q4 earnings on Thursday, January 30, 2025 at 04:05 PM.</p>
<p>Here's a breakdown of the earnings report.</p>
<h3>Earnings</h3>
<p>Bancorp beat estimated earnings by 2.0%, reporting an EPS of $1.15 versus an estimate of $1.13.</p>
<p>Revenue was up $2.14 million from the same period last year.</p>
<h3>Performance in Previous Earnings</h3>
<p>Last quarter the company missed on EPS by $0.08 which was followed by a 14.000000000000002% drop in the share price the next day.</p>
<p>Here's a look at Bancorp's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.12</td>
<td>1.07</td>
<td>1.05</td>
<td>0.95</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.04</td>
<td>1.07</td>
<td>1.06</td>
<td>0.95</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>99.31M</td>
<td>96.41M</td>
<td>116.51M</td>
<td>90.65M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>93.73M</td>
<td>93.80M</td>
<td>94.42M</td>
<td>92.16M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Bancorp management provided guidance for FY 2025, expecting earnings between $5.25 and $5.25 per share.</p>
<p>To track all earnings releases for Bancorp <a href="https://www.benzinga.com/quote/TBBK/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings Summary: Bancorp Q4

AAPL

ABCB

ALGM

APPF

Adtalem Global Education Inc. Common Stock

ATGE

BAFN

BBVA

BHLB

BOOT

CACC

CHKP

CIVB

CMCSA

CNOB

COUR

CSWI

CVCO

DECK

FBIZ

FCFS

FFWM

FINW

FISI

FLWS

FRME

GSIT

INTC

KLAC

KRNY

LPLA

MBLY

MBUU

NTCT

ONEW

PFSI

REAL

SCSC

SHEL

SILC

SIRI

SKYW

STBA

STEL

Earnings Scheduled For January 30, 2025

<p>Piper Sandler  analyst Frank Schiraldi   maintains Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBBK#NASDAQ">TBBK</a>) with a Overweight and raises the price target from $61 to $64.</p>


Piper Sandler Maintains Overweight on Bancorp, Raises Price Target to $64

<p><strong>Bancorp's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TBBK#NYSE">TBBK</a>) short percent of float has fallen 3.81% since its last report. The company recently reported that it has <strong>6.48 million shares sold short</strong>, which is 17.19% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 9.33 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest"><strong>List of the most shorted stocks</strong></a></p>
<h3>Bancorp Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731698129_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Bancorp has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.</p>
<h3>Comparing Bancorp's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Bancorp's peer group average for short interest as a percentage of float is 4.18%, which means the company has <strong>more</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Short Sellers

Short Ideas

Trading Ideas

How Is The Market Feeling About Bancorp?

EWBC

SCHW

Shares of banks and financial services stocks are trading higher. The sector has gained amid the 2024 US presidential election results.

ACNB

AMAL

AMTB

AROW

BANF

BANR

BCAL

BFST

BHRB

BMRC

BOKF

BPOP

BRKL

BSRR

BSVN

BUSE

CARE

CASH

CATY

CBAN

CBNK

CBSH

CCBG

CCNE

CFFN

CHCO

CLBK

COFS

CTBI

CUBI

CVBF

CZFS

DCOM

EBTC

EFSC

EGBN

EQBK

FBMS

FBNC

FCBC

FCNCA

FFBC

FFIC

FFIN

FIBK

FLIC

FMAO

FMBH

FMNB

FNLC

FRBA

FRST

FSBC

GABC

GBCI

GCBC

GNTY

GSBC

HAFC

HBCP

HBNC

HFBL

HFWA

HIFS

HMST

HOMB

HONE

HOPE

HTBI

HTBK

HTLF

Shares of banking-related companies are trading higher after Donald Trump won the US presidential election.

<p>U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 0.3% on Friday.</p>
<p>Shares of <strong>Capri Holdings Limited</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPRI#NYSE">CPRI</a>) fell sharply in today's pre-market trading following reports that a judge has blocked the company's<a href="https://www.benzinga.com/m-a/24/10/41533172/capri-holdings-stock-drops-by-half-after-judge-blocks-tapestry-merger"> pending merger with Tapestry.</a></p>
<p>Following an eight-day trial in which the U.S. Federal Trade Commission argued that a merger between Capri and Tapestry would remove competition from the U.S. handbag space, a U.S. judge has moved to block the pending merger, according to Reuters.</p>
<p>Capri shares tumbled 47.1% to $22.01 in pre-market trading.</p>
<p>Here are some big stocks recording losses in today's pre-market trading session.</p>
<ul>
<li><strong>Coursera, Inc</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COUR#NYSE">COUR</a>) shares dipped 19.2% to $6.16 in today's pre-market trading after the company issued fourth-quarter revenue guidance below estimates and cut its FY24 revenue guidance,</li>
<li><strong>The Bancorp, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBBK#NASDAQ">TBBK</a>) shares declined 15.4% to $46.51 following downbeat quarterly results.</li>
<li><strong>Joby Aviation, Inc</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JOBY#NYSE">JOBY</a>) dipped 8.1% to $5.55 in pre-market trading as the company announced the pricing of public offering of common stock.</li>
<li><strong>Tevogen Bio Holdings Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVGN#NASDAQ">TVGN</a>) shares fell 7.8% to $2.36 in pre-market trading. Tevogen Bio recently announced its Artificial Intelligence effort, Tevogen AI, has joined Microsoft for Startups.</li>
<li><strong>DexCom, Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>) shares fell 6.6% to $69.89 in pre-market trading following third-quarter results.</li>
<li><strong>Sibanye Stillwater Limited</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBSW#NYSE">SBSW</a>) declined 4.6% to $4.73 in pre-market trading after surging more than 12% on Thursday.</li>
<li><strong>The Boston Beer Company, Inc</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) shares fell 4% to $289.80 in pre-market trading following third-quarter results.</li>
<li><strong>Masimo Corporation</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MASI#NASDAQ">MASI</a>) shares fell 4% to $135.23 in pre-market trading. Masimo will report third quarter financial results, after the closing bell on Tuesday, Nov. 5.</li>
</ul>
<p><strong>Now Read This: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/markets/24/10/41528323/jim-cramer-says-hold-on-to-palantir-let-them-walk-it-up-warns-that-travere-therapeutics-is-losing-a">Jim Cramer Says &#8216;Hold On&#8217; To Palantir, &#8216;Let Them Walk It Up&#8217;; Warns That Travere Therapeutics Is Losing A &#8216;Ton Of Money&#8217;</a></strong></li>
</ul>


Pre-Market Outlook

Markets

Movers

CPRI

DXCM

JOBY

MASI

SBSW

TVGN

Capri, Coursera, DexCom And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Bancorp shares are trading lower after the company reported worse-than-expected Q3 financial results and issued FY24 EPS guidance below estimates.

<p>Shares of <strong>Deckers Outdoor Corporation</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>) rose sharply in today's pre-market trading after the company reported better-than-expected <a href="https://www.benzinga.com/news/earnings/24/10/41531479/deckers-outdoor-delivers-better-than-expected-q2-earnings-led-by-strength-in-hoka-ugg-brands">second-quarter financial results</a>.</p>
<p>Deckers reported second-quarter revenue of $1.31 billion, beating analyst estimates of $1.2 billion. The casual footwear and apparel company reported second-quarter earnings of $1.59, beating analyst estimates of $1.23 per share, according to Benzinga Pro.</p>
<p>Deckers Outdoor shares jumped 14% to $173.31 in the pre-market trading session.</p>
<p>Here are some other stocks moving in pre-market trading.</p>
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li><strong>Safe &amp; Green Holdings Corp</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGBX#NASDAQ">SGBX</a>) rose 108.5% to $2.19 in pre-market trading after dipping around 20% on Thursday.</li>
<li><strong>ARB IOT Group Limited</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBB#NASDAQ">ARBB</a>) gained 83.9% to $0.6070 in pre-market trading after falling over 10% on Thursday.</li>
<li><strong>Jeffs&#8217; Brands Ltd</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JFBR#NASDAQ">JFBR</a>) shares rose 60.6% to $0.44 in pre-market trading after the company announced it was granted a 180-day extension to regain Nasdaq compliance.</li>
<li><strong>Faraday Future Intelligent Electric Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIE#NASDAQ">FFIE</a>) shares surged 31% to $2.62 in pre-market trading. Faraday Future Partnered with UAE&#8217;s Royal Family for strategic expansion in Ras Al Khaimah.</li>
<li><strong>Lyell Immunopharma, Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYEL#NASDAQ">LYEL</a>) shares jumped 24.7% to $1.37 in pre-market trading after the company announced it will acquire privately-owned clinical-stage biotechnology company ImmPACT Bio.</li>
<li><strong>Inno Holdings Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INHD#NASDAQ">INHD</a>) rose 19.4% to $4.7200 in pre-market trading after declining 8% on Thursday.</li>
<li><strong>ImmunityBio, Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>) climbed 14.2% to $4.81 in pre-market trading after the company announced it dosed its first patients in its Phase 1 clinical study of CAR-NK cell therapy for relapsed B-Cell Non-Hodgkin Lymphoma.</li>
<li><strong>Tapestry, Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPR#NYSE">TPR</a>) gained 14.2% to $50.80 in pre-market trading as traders circulate a report alleging that a judge blocked the company&#8217;s proposed acquisition of Capri.</li>
<li><strong>CleanCore Solutions, Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZONE#NASDAQ">ZONE</a>) shares rose 12.8% to $1.67 in pre-market trading.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li><strong>Capri Holdings Limited</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPRI#NYSE">CPRI</a>) shares dipped 47.1% to $22.01 in pre-market trading following reports that a judge has blocked the company's pending merger with Tapestry.</li>
<li><strong>Monopar Therapeutics Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNPR#NASDAQ">MNPR</a>) shares fell 21.8% to $25.50 in pre-market trading. Monopar Therapeutics shares jumped 605% on Thursday after the company entered into an agreement with Alexion, AstraZeneca Rare Disease, for an exclusive worldwide license to ALXN-1840 for Wilson disease.</li>
<li><strong>Hepion Pharmaceuticals, In</strong>c (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEPA#NASDAQ">HEPA</a>) shares fell 20.2% to $0.58 in pre-market trading after gaining 12% on Thursday.</li>
<li><strong>Coursera, Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COUR#NYSE">COUR</a>) fell 19.2% to $6.16 in today's pre-market trading after the company issued fourth-quarter revenue guidance below estimates and cut its FY24 revenue guidance,</li>
<li><strong>Quince Therapeutics, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QNCX#NASDAQ">QNCX</a>) fell 18.2% to $0.9723 in pre-market trading after jumping 37% on Thursday.</li>
<li><strong>Alpha Technology Group Limited</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATGL#NASDAQ">ATGL</a>) fell 17.3% to $7.97 in pre-market trading after jumping 52% on Thursday.</li>
<li><strong>Bionomics Limited</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNOX#NASDAQ">BNOX</a>) declined 16.1% to $0.3020 in pre-market trading after jumping 24% on Thursday.</li>
<li><strong>The Bancorp, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBBK#NASDAQ">TBBK</a>) shares fell 15.4% to $46.51 following downbeat quarterly results.</li>
<li><strong>Farmmi, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FAMI#NASDAQ">FAMI</a>) shares declined 12.9% to $0.4180 in pre-market trading. Farmmi shares jumped 24% on Thursday after the company announced it entered into a strategic cooperation agreement to further expand its logistic services business and potentially bring in an additional $10 million in annual orders</li>
<li><strong>Joby Aviation, Inc</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JOBY#NYSE">JOBY</a>) fell 8.1% to $5.55 in pre-market trading as the company announced the pricing of public offering of common stock.</li>
</ul>
<p>N<strong>ow Read This: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/markets/24/10/41528323/jim-cramer-says-hold-on-to-palantir-let-them-walk-it-up-warns-that-travere-therapeutics-is-losing-a">Jim Cramer Says &#8216;Hold On&#8217; To Palantir, &#8216;Let Them Walk It Up&#8217;; Warns That Travere Therapeutics Is Losing A &#8216;Ton Of Money&#8217;</a></strong></li>
</ul>


ARBB

ATGL

BNOX

FAMI

FFIE

HEPA

IBRX

INHD

JFBR

LYEL

MNPR

QNCX

SGBX

ZONE

Why Deckers Outdoor Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Press Releases

The Bancorp Announces Todd Brockman to Join Its Board of Directors

The Bancorp, Inc. Sets Third Quarter 2024 Financial Results Release Date and Conference Call

The Bancorp, Inc. Reports its Third Quarter Financial Results

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Bancorp, Inc. - TBBK

The Bancorp, Inc. Sets Fourth Quarter and Fiscal 2024 Financial Results Release Date and Conference Call

The Bancorp Appoints Dwayne Allen to Its Board of Directors

Comments

Bancorp

Bancorp (TBBK) 옵션

Bancorp (NASDAQ:TBBK) 주식, 옵션 체인

뉴스

파트너 / 기고자

벤징가 글로벌